Is Gwph A Good Buy Apr 2026

GW Pharmaceuticals () is no longer available for purchase as an independent stock. It was acquired by Jazz Pharmaceuticals (Nasdaq: JAZZ ) on May 5, 2021, for approximately $7.2 billion. Acquisition Details

If you are interested in the assets formerly owned by GW Pharmaceuticals, you must now look at . To determine if JAZZ is a "good buy," consider the following factors derived from the merger:

: Following the completion of the merger, GWPH was delisted from the Nasdaq. is gwph a good buy

: The acquisition was driven largely by GW's blockbuster cannabis-derived drug, Epidiolex , which treats rare forms of childhood epilepsy. How to Invest Now

: Shareholders of GWPH American Depositary Shares (ADS) received $200 in cash and $20 in Jazz ordinary shares for each ADS held. GW Pharmaceuticals () is no longer available for

For current valuation and performance, you should review the latest financial data for on platforms like Yahoo Finance or Seeking Alpha .

: The deal was expected to deliver double-digit revenue growth and be accretive to earnings shortly after closing. To determine if JAZZ is a "good buy,"

: Beyond Epidiolex, Jazz acquired GW's pipeline of cannabinoid-based drugs for conditions like MS-related spasticity, autism, and schizophrenia.